I'm quoted in Monday's Kansas City Star. The report is what is known in journalese as a "localization" of a national or global story. The local angle is NanoScale Materials Inc., of Manhattan, Kan., and its Fast-Act nanomaterials that the company says can neutralize toxic chemicals and biowarfare agents. Reporter Scott Canon sets the local and global scene in a well-written first three paragraphs:
- Ken Klabunde is an explorer in a world only a tad bigger than the atom.
He wanders the frontier of nanoscience, where forces like gravity begin to fade before the atomic scale's quantum physics take over.
"It's a new realm of matter," said Klabunde, the founder of NanoScale Materials Inc. He hopes to revolutionize industry and maybe make a few bucks along the way.
Such is the beauty, and perhaps the peril, of nanotechnology.
- The same scientists who salivate at the most fantastic possibilities sniff danger, too. They wonder whether robots smaller than bacteria will leave a wasteland of "gray goo" as they reproduce and devour all they touch.
More realistically, they fear an unleashing of new poisons so small they could slip into the body through your fingertips.
- "With a few exceptions, investors are kind of reluctant to put their money into basically a science project," said Howard Lovy, editor of the nanotech industry journal Small Times. "We're not seeing people scratching a business plan on a napkin and raising a few million bucks."